Haemonetics (HAE) News Today $64.19 -0.26 (-0.40%) As of 10:28 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period A Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To EquityMarch 24 at 3:52 PM | finance.yahoo.com4,696 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Cibc World Markets CorpCibc World Markets Corp bought a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,696 shares of the medical instruments supplier's stock, valued at appMarch 24 at 4:05 AM | marketbeat.com15,802 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Kiker Wealth Management LLCKiker Wealth Management LLC purchased a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,802 shares of the medical insMarch 22 at 6:15 AM | marketbeat.comBoston Partners Grows Holdings in Haemonetics Co. (NYSE:HAE)Boston Partners increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 27.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 536,262 shares of the medical instruments supplier's stock after acqMarch 21, 2025 | marketbeat.comIntech Investment Management LLC Acquires 24,009 Shares of Haemonetics Co. (NYSE:HAE)Intech Investment Management LLC increased its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 107.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,338 shares of the medical instrMarch 21, 2025 | marketbeat.com3 Healthcare Stocks Walking a Fine LineMarch 20, 2025 | finance.yahoo.comThrivent Financial for Lutherans Grows Stock Position in Haemonetics Co. (NYSE:HAE)Thrivent Financial for Lutherans increased its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 14.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,264,294 shares of the medical instruments sMarch 20, 2025 | marketbeat.comNeedham & Company LLC Cuts Haemonetics (NYSE:HAE) Price Target to $104.00Needham & Company LLC lowered their price objective on Haemonetics from $108.00 to $104.00 and set a "buy" rating on the stock in a research report on Tuesday.March 19, 2025 | marketbeat.comWilliam Blair Investment Management LLC Purchases 101,807 Shares of Haemonetics Co. (NYSE:HAE)William Blair Investment Management LLC boosted its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 29.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 446,258 shares of the medical instrumMarch 19, 2025 | marketbeat.comHaemonetics price target lowered to $104 from $108 at NeedhamMarch 18, 2025 | markets.businessinsider.comHaemonetics (HAE) Gets a Buy from NeedhamMarch 18, 2025 | markets.businessinsider.comHaemonetics Co. (NYSE:HAE) Shares Sold by Royce & Associates LPRoyce & Associates LP trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 4.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,153,268 shares of the medical instruments supplier's stock after selling 57,278 shares durMarch 17, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in Haemonetics Co. (NYSE:HAE)Raymond James Financial Inc. purchased a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 243,364 shares of the medical instruments supplier's stock, valued at apprMarch 17, 2025 | marketbeat.comFY2025 EPS Estimate for Haemonetics Decreased by AnalystMarch 17, 2025 | americanbankingnews.comHaemonetics FY2025 EPS Estimate Reduced by Zacks ResearchHaemonetics Co. (NYSE:HAE - Free Report) - Equities researchers at Zacks Research reduced their FY2025 EPS estimates for shares of Haemonetics in a research note issued on Thursday, March 13th. Zacks Research analyst R. Department now forecasts that the medical instruments supplier will earn $4.5March 17, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Holdings in Haemonetics Co. (NYSE:HAE)Charles Schwab Investment Management Inc. grew its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 1.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 551,193 shares of the medical instruments supplier's stock after purchasing an additionaMarch 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Haemonetics Co. (NYSE:HAE)Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 14.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 252,142 shares of the medical instruments supplier's stock after acquiring anMarch 14, 2025 | marketbeat.com106,055 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Wealthfront Advisers LLCWealthfront Advisers LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 106,055 shares of the medical instruments supplier's stock, valued at approximately $7,849,0March 13, 2025 | marketbeat.comHow Do Investors Really Feel About Haemonetics?March 12, 2025 | benzinga.comHaemonetics Co. (NYSE:HAE) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. lowered its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 271,082 shares of theMarch 12, 2025 | marketbeat.comTradeLink Capital LLC Invests $902,000 in Haemonetics Co. (NYSE:HAE)TradeLink Capital LLC purchased a new position in Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,557 shares of the medical instruments supplier's stock, valued at approximatMarch 10, 2025 | marketbeat.comAMG National Trust Bank Acquires New Position in Haemonetics Co. (NYSE:HAE)AMG National Trust Bank acquired a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 9,744 shares of the medical instruments supplier's stock, valued atMarch 9, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Bought by Global Alpha Capital Management Ltd.Global Alpha Capital Management Ltd. increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 70.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,101 shares of the medical instrumenMarch 9, 2025 | marketbeat.comBank of New York Mellon Corp Sells 15,785 Shares of Haemonetics Co. (NYSE:HAE)Bank of New York Mellon Corp lessened its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 386,489 shares of the medical instruments supplier's stock after selMarch 9, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has given a hold raMarch 6, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Sees Large Growth in Short InterestHaemonetics Co. (NYSE:HAE - Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 6,830,000 shares, an increase of 30.3% from the January 31st total of 5,240,000 shares. Based on an average trading volume of 792,300 shares, the days-to-cover ratio is presently 8.6 days. Currently, 13.8% of the shares of the company are sold short.March 5, 2025 | marketbeat.comHaemonetics appoints new executive leadershiMarch 5, 2025 | investing.comJ.P. Morgan Remains a Buy on Haemonetics (HAE)March 4, 2025 | markets.businessinsider.comHaemonetics Names Chan Chief Operating OfficerMarch 4, 2025 | marketwatch.comHaemonetics announces updates to its Executive Leadership teamMarch 4, 2025 | markets.businessinsider.comHaemonetics Announces Executive Leadership UpdatesMarch 3, 2025 | prnewswire.comPharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint CongressMarch 3, 2025 | globenewswire.comHaemonetics Co. (NYSE:HAE) Shares Bought by Fisher Asset Management LLCFisher Asset Management LLC boosted its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 3.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 711,774 shares of the medical instruments supplier's stock after bMarch 2, 2025 | marketbeat.comLos Angeles Capital Management LLC Sells 7,539 Shares of Haemonetics Co. (NYSE:HAE)Los Angeles Capital Management LLC reduced its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 31.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,415 shares of the medical instruments supplier's stock aMarch 2, 2025 | marketbeat.comHaemonetics (NYSE:HAE) Shares Up 3.5% - Should You Buy?Haemonetics (NYSE:HAE) Shares Up 3.5% - Here's WhyFebruary 24, 2025 | marketbeat.comHaemonetics to Present at Raymond James 46th Annual Institutional Investors ConferenceFebruary 24, 2025 | prnewswire.comQ3 EPS Estimates for Haemonetics Increased by Zacks ResearchHaemonetics Co. (NYSE:HAE - Free Report) - Equities research analysts at Zacks Research boosted their Q3 2026 earnings per share estimates for shares of Haemonetics in a research note issued on Monday, February 17th. Zacks Research analyst R. Department now anticipates that the medical instrumentFebruary 21, 2025 | marketbeat.comVan ECK Associates Corp Buys Shares of 39,620 Haemonetics Co. (NYSE:HAE)Van ECK Associates Corp bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 39,620 shares of the medical instruments supplier's stFebruary 21, 2025 | marketbeat.com4,086 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Empowered Funds LLCEmpowered Funds LLC acquired a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 4,086 shares of the medical instruments supplier's stock, valued at approximately $319,000. A numbFebruary 21, 2025 | marketbeat.comHaemonetics: Almost Blood In The StreetsFebruary 20, 2025 | seekingalpha.comHaemonetics FY2025 EPS Forecast Lowered by Zacks ResearchHaemonetics Co. (NYSE:HAE - Free Report) - Zacks Research lowered their FY2025 earnings per share estimates for Haemonetics in a research note issued on Monday, February 17th. Zacks Research analyst R. Department now expects that the medical instruments supplier will earn $4.56 per share for theFebruary 20, 2025 | marketbeat.comVontobel Holding Ltd. Acquires 8,133 Shares of Haemonetics Co. (NYSE:HAE)Vontobel Holding Ltd. boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 166.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,011 shares of the medical instruments supplier's stock afterFebruary 19, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Short Interest Up 5.6% in JanuaryHaemonetics Co. (NYSE:HAE - Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 5,240,000 shares, a growth of 5.6% from the January 15th total of 4,960,000 shares. Approximately 10.6% of the shares of the company are sold short. Based on an average trading volume of 781,800 shares, the short-interest ratio is currently 6.7 days.February 18, 2025 | marketbeat.comAstria Therapeutics: A High-Conviction Bet On HAEFebruary 17, 2025 | seekingalpha.comHaemonetics (NYSE:HAE) Downgraded by StockNews.com to HoldStockNews.com downgraded shares of Haemonetics from a "buy" rating to a "hold" rating in a research note on Saturday.February 15, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Position Increased by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC raised its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 0.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 801,049 shares of the medical insFebruary 14, 2025 | marketbeat.comHaemonetics' (NYSE:HAE) Earnings Offer More Than Meets The EyeFebruary 13, 2025 | finance.yahoo.comRetirement Systems of Alabama Sells 116,501 Shares of Haemonetics Co. (NYSE:HAE)Retirement Systems of Alabama cut its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 65.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,068 shares of the medical instruments supplier's stock after sellingFebruary 11, 2025 | marketbeat.comJanney Montgomery Scott LLC Makes New Investment in Haemonetics Co. (NYSE:HAE)Janney Montgomery Scott LLC bought a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 5,147 shares of the medical instruments supplier's stock, valued atFebruary 11, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC lowered its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 82.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,732 shares of the medical instruments supplier's stock after selling 8,100 shares during the period. SG Americas SFebruary 11, 2025 | marketbeat.com Remove Ads Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address HAE Media Mentions By Week HAE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼0.550.63▲Average Medical News Sentiment HAE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼126▲HAE Articles Average Week Remove Ads Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Align Technology News Merit Medical Systems News ICU Medical News DENTSPLY SIRONA News QuidelOrtho News Neogen News STAAR Surgical News Cerus News OraSure Technologies News Anika Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
